What is Cyclobenzaprine Yuredol used for? (Cyclobenzaprine Yuredol para que sirve?)

The drug is designed to quickly relieve muscle cramps. It relaxes the muscles and helps cope with myalgia without directly affecting the muscular frame. The active ingredient of the drug is cyclobenzaprine. It is an effective myotropic antispasmodic that works regardless of the cause of muscle pain. It has been well studied and is recognized as safe for patients over 18 years of age.

Cyclobenzaprine is more than 90% bound to plasma albumin and globulin. Its bioavailability ranges from 33 to 55%. Maximum blood concentration is reached 8 hours after oral administration.

Cyclobenzaprine affects brain stem cells. The active substance partially interferes with the transmission of nerve impulses from the CNS to the periphery and restructures the spinal cord. This provides a relaxing effect.

When using the drug Yuredol, tonic activity is reduced; spasms, cramps, tremors are eliminated; a sedative effect is provided.

Hypertonicity and pain under the influence of cyclobenzaprine disappear. At the same time, there is no effect on the very muscular frame and synapses. In spasticity against the background of cerebral palsy, the drug is ineffective, but it can be used as a concomitant therapy for tetanus.

Yuredol belongs to the group of muscle relaxants and is used to treat back and neck pain. The active ingredient of the drug is cyclobenzaprine. It helps to relax the muscles and reduce muscle tone. Under the action of the medication, the hyperactivity of the muscles decreases. At the same time, the drug has no effect on their structure.

Back pain occurs in nearly 75% of people of all ages. The drug allows getting rid of this unpleasant phenomenon in just 2-3 weeks. Longer treatment is not required, because usually this period is enough to eliminate the problem. Yuredol 10 mg acts at the level of the brain stem. A significant improvement in the state of health and disappearance of pronounced pain syndrome was detected after 14 days in 90% of patients who took the drug. If we take into account clinical studies, we can conclude that already on the 4th day the pain decreases and mobility improves.